Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
strategic assets
|
| gptkbp:advertising |
targeted therapies
|
| gptkbp:budget |
financial performance
|
| gptkbp:businessModel |
biotech innovation
|
| gptkbp:CEO |
Faheem_Hasnain
|
| gptkbp:clinicalTrials |
Phase 1
rare diseases Phase 2 Phase 3 autoimmune diseases chronic diseases infectious diseases peer-reviewed publications biopharmaceutical company multiple sites published in journals patient-centric approach various drug candidates |
| gptkbp:collaborations |
academic institutions
partnerships with universities |
| gptkbp:community_outreach |
health education programs
|
| gptkbp:community_service |
engagement with communities.
|
| gptkbp:culturalHeritage |
workplace culture
|
| gptkbp:employeeCount |
over 100
|
| gptkbp:financialPerformance |
public market fluctuations
|
| gptkbp:focus |
biopharmaceuticals
|
| gptkbp:focus_area |
oncology
cardiovascular diseases immunology metabolic diseases |
| gptkbp:founded |
2015
|
| gptkbp:founder |
Faheem_Hasnain
|
| gptkbp:funding |
Series A
Series B Series C |
| gptkbp:future_plans |
innovation in drug development
expansion of pipeline |
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gossamer Bio
|
| gptkbp:investmentFocus |
venture capital
various venture capital firms transparent communication |
| gptkbp:leads |
GB004
GB001 GB002 |
| gptkbp:mission |
transforming the lives of patients
|
| gptkbp:partnerships |
multiple pharmaceutical companies
biopharmaceutical collaborations |
| gptkbp:patentCitation |
intellectual property protection
|
| gptkbp:platforms |
drug_discovery_technologies
|
| gptkbp:publications |
research findings
|
| gptkbp:reach |
international collaborations
|
| gptkbp:recruitment |
diverse populations
|
| gptkbp:regulatoryCompliance |
gptkb:FDA
|
| gptkbp:research |
clinical outcomes
|
| gptkbp:researchAndDevelopment |
drug_discovery
|
| gptkbp:safety_features |
drug candidates
|
| gptkbp:social_responsibility |
community engagement
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
GOSS
|
| gptkbp:supportRole |
experts in biotechnology
|
| gptkbp:sustainability_initiatives |
environmental responsibility
|
| gptkbp:team |
experienced executives
|
| gptkbp:training |
professional development
|
| gptkbp:tributaryOf |
multiple therapeutic areas
|
| gptkbp:website |
www.gossamerbio.com
|